Sep 17, 2026
•
4 min read
A hospital drug since the 1960s and a wellness product since about 2015 — and the evidence behind those two oxytocins is not remotely the same.
Sep 7, 2026
The obesity drug that is not a GLP-1 — what cagrilintide is, what the trials actually showed, and why it is mostly discussed as half of something else.
Aug 31, 2026
5 min read
Retatrutide is the three-receptor weight-loss injection posting the biggest numbers anyone has recorded. Here is what it does, and what is still unknown.
Aug 24, 2026
6 min read
The basics on TB-500 — what it is, how it works, and what the evidence shows — plus the news worth your time.
semaglutide
+3
Aug 10, 2026
A brief explanation on Ipamorelin — what it is, how it works, and what the evidence shows — plus the news worth your time.
ghk-cu
+5
Aug 3, 2026
A description on Tesamorelin — what it is, how it works, and what the evidence shows — plus the news worth your time.
